| abstract |
The present invention relates to a method for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for the treatment of inflammatory diseases such as arthritic tissue and / or damage to the periarticular tissue caused by osteoarthritis or rheumatoid arthritis Lt; / RTI > microparticle formulation for use in slowing, arresting, or reversing structural damage to tissue caused by < RTI ID = 0.0 > The use of corticosteroid microparticulate preparations as topical (topical) dosage forms in sustained release dosage forms (with or without an immediate release component) that results in a clinically meaningless effect on the production of endogenous cortisol or an efficacy accompanied by an unmeasurable effect . |